| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.13B | +23.2% |
| Gross profit | ¥0.06B | — |
| Operating income | ¥0.00B | — |
| Net income | ¥0.01B | +125.3% |
| Gross margin | 47.7% | Net margin 5.5% |
| Revenue Q/Q | -22.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.07B | 52.3% |
| R&D | ¥0.03B | 22.6% |
| SG&A | ¥0.04B | 30.7% |
| Tax & other | ¥-0.00B | -2.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
汇成真空 ・ 昊帆生物 ・ 仁信新材 ・ 宏景科技 ・ 溯联股份 ・ 星源卓镁 ・ 英特科技 ・ 华人健康 ・ 安培龙 ・ 协昌科技 ・ 阿莱德 ・ 波长光电
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies